Lundbeckfond Invest A/S - Insider Non-Derivative Transactions at Lexeo Therapeutics, Inc. (LXEO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Nov 7, 2023, Lundbeckfond Invest A/S's relationship to Lexeo Therapeutics, Inc. (LXEO) is TenPercentOwner, and currently has 1,835,959 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LXEO insiders.

Data Source: SEC.
Lundbeckfond Invest A/S - Insider Non-Derivative Transactions of LXEO Common Stock
Lundbeckfond Invest A/S - Insider Non-Derivative Transactions at LXEO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Nov 8, 2023 C -- (Common Stock) 1321474 0 1321474
Nov 8, 2023 C -- (Common Stock) 287213 0 1608687
Nov 8, 2023 P -- (Common Stock) 227272 11 1835959